Skip to content

Clinical trials

Rectal Neoplasms trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Country / region: India Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20092
20101
20121
20201
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed3
Active, not recruiting2
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tata Memorial Centre3
Amgen1
GEM Hospital & Research Center1
International Atomic Energy Agency1
Mast Therapeutics, Inc.1
NantCell, Inc.1
National Cancer Centre, Singapore1
PVS Memorial Hospital1
Pfizer1
Rajiv Gandhi Cancer Institute & Research Center, India1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms13
Colonic Neoplasms6
Colorectal Neoplasms4
Intestinal Diseases2
Neoplasm Metastasis2
Adenocarcinoma1
Colonic Diseases1
Digestive System Diseases1
Digestive System Neoplasms1
Fecal Incontinence1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.